Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Feb;52(2):112–117. doi: 10.1136/jcp.52.2.112

Relation of cervical glandular intraepithelial neoplasia to microinvasive and invasive adenocarcinoma of the uterine cervix: a study of 121 cases.

K Kurian 1, A al-Nafussi 1
PMCID: PMC501054  PMID: 10396238

Abstract

AIMS: To examine the relation between invasive adenocarcinoma and its alleged precursor, cervical glandular intraepithelial neoplasia (CGIN), and to assess the management and outcome of CGIN and the validity of using the term "microinvasive adenocarcinoma." METHODS: The clinical and pathological features of 121 cases of glandular neoplasia of the cervix diagnosed between the years 1990 to 1995 were examined for the following: histological diagnosis, smear records, type of treatment, the association between the precursor lesions and invasive disease, and follow up. RESULTS: 27 cases were identified as low grade CGIN (L-CGIN) and 38 as high grade CGIN (H-CGIN), 10 as microinvasive adenocarcinoma (less than 5 mm in depth), and 46 as invasive adenocarcinoma. The ratio of non-invasive to invasive disease was 1.12:1. The mean age of women was 39, 43, 43, and 48 years for L-CGIN, H-CGIN, microinvasive, and invasive adenocarcinoma, respectively. L-CGIN was seen in 13% and 18% of H-CGIN and microinvasive disease, respectively. H-CGIN was seen in 100% of microinvasive and 26% of invasive adenocarcinomas. The available smears before diagnosis predicted 59% of L-CGIN, 70% of H-CIGN, 100% of microinvasive adenocarcinoma, and 32% of invasive adenocarcinomas. Treatment of 74% of L-CGIN, 52% of H-CIGN, and 10% of microinvasive adenocarcinoma was by diathermy loop excision only. The remaining cases had hysterectomy. Residual disease was found in 43%, 50%, and 33% of hysterectomies for L-CGIN, H-CGIN, and microinvasive adenocarcinoma, respectively. This is correlated with positive margins, or disease within 3 mm of margins on loop specimens. Cervical smear follow up for two to seven years revealed no recurrence of glandular lesions in any of the cases of CGIN or microinvasive adenocarcinoma. CONCLUSIONS: Precursor glandular lesions tend to progress to invasive carcinoma. There is a progressive increase in age of patients from L-CGIN to invasive disease, a span of approximately 10 years. There is a high association between H-CGIN and invasive disease. In the management of such alleged precursors, it is important to ensure adequate free margins of at least 3 mm. Microinvasive adenocarcinoma appears to have an excellent prognosis if treated by hysterectomy.

Full text

PDF
112

Images in this article

113Image
on p.113
113Image
on p.113
114Image
on p.114
114Image
on p.114

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen E. S., Arffmann E. Adenocarcinoma in situ of the uterine cervix: a clinico-pathologic study of 36 cases. Gynecol Oncol. 1989 Oct;35(1):1–7. doi: 10.1016/0090-8258(89)90001-2. [DOI] [PubMed] [Google Scholar]
  2. Anderson M. C. Glandular lesions of the cervix: diagnostic and therapeutic dilemmas. Baillieres Clin Obstet Gynaecol. 1995 Mar;9(1):105–119. doi: 10.1016/s0950-3552(05)80360-8. [DOI] [PubMed] [Google Scholar]
  3. Biscotti C. V., Gero M. A., Toddy S. M., Fischler D. F., Easley K. A. Endocervical adenocarcinoma in situ: an analysis of cellular features. Diagn Cytopathol. 1997 Nov;17(5):326–332. doi: 10.1002/(sici)1097-0339(199711)17:5<326::aid-dc4>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  4. Boddington M. M., Spriggs A. I., Cowdell R. H. Adenocarcinoma of the uterine cervix: cytological evidence of a long preclinical evolution. Br J Obstet Gynaecol. 1976 Nov;83(11):900–903. doi: 10.1111/j.1471-0528.1976.tb00770.x. [DOI] [PubMed] [Google Scholar]
  5. Boon M. E., Baak J. P., Kurver P. J., Overdiep S. H., Verdonk G. W. Adenocarcinoma in situ of the cervix: an underdiagnosed lesion. Cancer. 1981 Aug 1;48(3):768–773. doi: 10.1002/1097-0142(19810801)48:3<768::aid-cncr2820480318>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  6. Bousfield L., Pacey F., Young Q., Krumins I., Osborn R. Expanded cytologic criteria for the diagnosis of adenocarcinoma in situ of the cervix and related lesions. Acta Cytol. 1980 Jul-Aug;24(4):283–296. [PubMed] [Google Scholar]
  7. Brinton L. A., Herrero R., Reeves W. C., de Britton R. C., Gaitan E., Tenorio F. Risk factors for cervical cancer by histology. Gynecol Oncol. 1993 Dec;51(3):301–306. doi: 10.1006/gyno.1993.1294. [DOI] [PubMed] [Google Scholar]
  8. Casper G. R., Ostör A. G., Quinn M. A. A clinicopathologic study of glandular dysplasia of the cervix. Gynecol Oncol. 1997 Jan;64(1):166–170. doi: 10.1006/gyno.1996.4528. [DOI] [PubMed] [Google Scholar]
  9. Christopherson W. M., Nealon N., Gray L. A., Sr Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri. Cancer. 1979 Sep;44(3):975–983. doi: 10.1002/1097-0142(197909)44:3<975::aid-cncr2820440327>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  10. Cullimore J. E., Luesley D. M., Rollason T. P., Byrne P., Buckley C. H., Anderson M., Williams D. R., Waddell C., Hudson E., Shafi M. I. A prospective study of conization of the cervix in the management of cervical intraepithelial glandular neoplasia (CIGN)--a preliminary report. Br J Obstet Gynaecol. 1992 Apr;99(4):314–318. doi: 10.1111/j.1471-0528.1992.tb13730.x. [DOI] [PubMed] [Google Scholar]
  11. Cullimore J. E., Luesley D. M., Rollason T. P., Waddell C., Williams D. R. A case of glandular intraepithelial neoplasia involving the cervix and vagina. Gynecol Oncol. 1989 Aug;34(2):249–252. doi: 10.1016/0090-8258(89)90153-4. [DOI] [PubMed] [Google Scholar]
  12. Denehy T. R., Gregori C. A., Breen J. L. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix. Obstet Gynecol. 1997 Jul;90(1):1–6. doi: 10.1016/S0029-7844(97)00122-1. [DOI] [PubMed] [Google Scholar]
  13. Duggan M. A., McGregor S. E., Benoit J. L., Inoue M., Nation J. G., Stuart G. C. The human papillomavirus status of invasive cervical adenocarcinoma: a clinicopathological and outcome analysis. Hum Pathol. 1995 Mar;26(3):319–325. doi: 10.1016/0046-8177(95)90065-9. [DOI] [PubMed] [Google Scholar]
  14. Gloor E., Hurlimann J. Cervical intraepithelial glandular neoplasia (adenocarcinoma in situ and glandular dysplasia). A correlative study of 23 cases with histologic grading, histochemical analysis of mucins, and immunohistochemical determination of the affinity for four lectins. Cancer. 1986 Sep 15;58(6):1272–1280. doi: 10.1002/1097-0142(19860915)58:6<1272::aid-cncr2820580616>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  15. Gloor E., Ruzicka J. Morphology of adenocarcinoma in situ of the uterine cervix: a study of 14 cases. Cancer. 1982 Jan 15;49(2):294–302. doi: 10.1002/1097-0142(19820115)49:2<294::aid-cncr2820490215>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  16. Gold M., Dunton C. J., Murray J., Macones G., Hanau C., Carlson J. A., Jr Loop electrocautery excisional procedure: therapeutic effectiveness as an ablation and a conization equivalent. Gynecol Oncol. 1996 May;61(2):241–244. doi: 10.1006/gyno.1996.0132. [DOI] [PubMed] [Google Scholar]
  17. Hopkins M. P., Roberts J. A., Schmidt R. W. Cervical adenocarcinoma in situ. Obstet Gynecol. 1988 Jun;71(6 Pt 1):842–844. [PubMed] [Google Scholar]
  18. Houghton S. J., Shafi M. I., Rollason T. P., Luesley D. M. Is loop excision adequate primary management of adenocarcinoma in situ of the cervix? Br J Obstet Gynaecol. 1997 Mar;104(3):325–329. doi: 10.1111/j.1471-0528.1997.tb11462.x. [DOI] [PubMed] [Google Scholar]
  19. Hunter R. W., Hammond I. G. A case of multicentric glandular tumorigenesis of the female upper genital tract: implications for management. Aust N Z J Obstet Gynaecol. 1993 Aug;33(3):333–334. doi: 10.1111/j.1479-828x.1993.tb02103.x. [DOI] [PubMed] [Google Scholar]
  20. Im D. D., Duska L. R., Rosenshein N. B. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease. Gynecol Oncol. 1995 Nov;59(2):179–182. doi: 10.1006/gyno.1995.0003. [DOI] [PubMed] [Google Scholar]
  21. Jackson S. R., Hollingworth T. A., Anderson M. C., Johnson J., Hammond R. H. Glandular lesions of the cervix-cytological and histological correlation. Cytopathology. 1996 Feb;7(1):10–16. doi: 10.1046/j.1365-2303.1996.37382373.x. [DOI] [PubMed] [Google Scholar]
  22. Jaworski R. C. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix. Semin Diagn Pathol. 1990 Aug;7(3):190–204. [PubMed] [Google Scholar]
  23. Kashimura M., Shinohara M., Oikawa K., Hamasaki K., Sato H. An adenocarcinoma in situ of the uterine cervix that developed into invasive adenocarcinoma after 5 years. Gynecol Oncol. 1990 Jan;36(1):128–133. doi: 10.1016/0090-8258(90)90123-3. [DOI] [PubMed] [Google Scholar]
  24. Kaspar H. G., Dinh T. V., Doherty M. G., Hannigan E. V., Kumar D. Clinical implications of tumor volume measurement in stage I adenocarcinoma of the cervix. Obstet Gynecol. 1993 Feb;81(2):296–300. [PubMed] [Google Scholar]
  25. Keyhani-Rofagha S., Brewer J., Prokorym P. Comparative cytologic findings of in situ and invasive adenocarcinoma of the uterine cervix. Diagn Cytopathol. 1995 Mar;12(2):120–125. doi: 10.1002/dc.2840120206. [DOI] [PubMed] [Google Scholar]
  26. Laverty C. R., Farnsworth A., Thurloe J., Bowditch R. The reliability of a cytological prediction of cervical adenocarcinoma in situ. Aust N Z J Obstet Gynaecol. 1988 Nov;28(4):307–312. doi: 10.1111/j.1479-828x.1988.tb01688.x. [DOI] [PubMed] [Google Scholar]
  27. Leminen A., Paavonen J., Forss M., Wahlström T., Vesterinen E. Adenocarcinoma of the uterine cervix. Cancer. 1990 Jan 1;65(1):53–59. doi: 10.1002/1097-0142(19900101)65:1<53::aid-cncr2820650112>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  28. Luesley D. M., Jordan J. A., Woodman C. B., Watson N., Williams D. R., Waddell C. A retrospective review of adenocarcinoma-in-situ and glandular atypia of the uterine cervix. Br J Obstet Gynaecol. 1987 Jul;94(7):699–703. doi: 10.1111/j.1471-0528.1987.tb03179.x. [DOI] [PubMed] [Google Scholar]
  29. Mulvany N., Ostör A. Microinvasive adenocarcinoma of the cervix: a cytohistopathologic study of 40 cases. Diagn Cytopathol. 1997 May;16(5):430–436. doi: 10.1002/(sici)1097-0339(199705)16:5<430::aid-dc9>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  30. Muntz H. G., Bell D. A., Lage J. M., Goff B. A., Feldman S., Rice L. W. Adenocarcinoma in situ of the uterine cervix. Obstet Gynecol. 1992 Dec;80(6):935–939. [PubMed] [Google Scholar]
  31. Muntz H. G. Can cervical adenocarcinoma in situ be safely managed by conization alone? Gynecol Oncol. 1996 Jun;61(3):301–303. doi: 10.1006/gyno.1996.0146. [DOI] [PubMed] [Google Scholar]
  32. Nicklin J. L., Wright R. G., Bell J. R., Samaratunga H., Cox N. C., Ward B. G. A clinicopathological study of adenocarcinoma in situ of the cervix. The influence of cervical HPV infection and other factors, and the role of conservative surgery. Aust N Z J Obstet Gynaecol. 1991 May;31(2):179–183. doi: 10.1111/j.1479-828x.1991.tb01814.x. [DOI] [PubMed] [Google Scholar]
  33. Ostör A. G., Pagano R., Davoren R. A., Fortune D. W., Chanen W., Rome R. Adenocarcinoma in situ of the cervix. Int J Gynecol Pathol. 1984;3(2):179–190. doi: 10.1097/00004347-198402000-00006. [DOI] [PubMed] [Google Scholar]
  34. Ostör A., Rome R., Quinn M. Microinvasive adenocarcinoma of the cervix: a clinicopathologic study of 77 women. Obstet Gynecol. 1997 Jan;89(1):88–93. doi: 10.1016/s0029-7844(96)00386-9. [DOI] [PubMed] [Google Scholar]
  35. Parazzini F., La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol. 1990 Oct;39(1):40–46. doi: 10.1016/0090-8258(90)90396-3. [DOI] [PubMed] [Google Scholar]
  36. Parazzini F., La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol. 1990 Oct;39(1):40–46. doi: 10.1016/0090-8258(90)90396-3. [DOI] [PubMed] [Google Scholar]
  37. Poynor E. A., Barakat R. R., Hoskins W. J. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol. 1995 May;57(2):158–164. doi: 10.1006/gyno.1995.1118. [DOI] [PubMed] [Google Scholar]
  38. Qizilbash A. H. In-situ and microinvasive adenocarcinoma of the uterine cervix. A clinical, cytologic and histologic study of 14 cases. Am J Clin Pathol. 1975 Aug;64(2):155–170. doi: 10.1093/ajcp/64.2.155. [DOI] [PubMed] [Google Scholar]
  39. Rollason T. P., Cullimore J., Bradgate M. G. A suggested columnar cell morphological equivalent of squamous carcinoma in situ with early stromal invasion. Int J Gynecol Pathol. 1989;8(3):230–236. doi: 10.1097/00004347-198909000-00006. [DOI] [PubMed] [Google Scholar]
  40. Siziopikou K. P., Wang H. H., Abu-Jawdeh G. Cytologic features of neoplastic lesions in endocervical glands. Diagn Cytopathol. 1997 Jul;17(1):1–7. doi: 10.1002/(sici)1097-0339(199707)17:1<1::aid-dc1>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  41. Stockton D., Cooper P., Lonsdale R. N. Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia. J Med Screen. 1997;4(1):40–43. doi: 10.1177/096914139700400112. [DOI] [PubMed] [Google Scholar]
  42. Teshima S., Shimosato Y., Kishi K., Kasamatsu T., Ohmi K., Uei Y. Early stage adenocarcinoma of the uterine cervix. Histopathologic analysis with consideration of histogenesis. Cancer. 1985 Jul 1;56(1):167–172. doi: 10.1002/1097-0142(19850701)56:1<167::aid-cncr2820560126>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  43. Umezaki K., Sanezumi M., Okada H., Okamura A., Tsubra A., Kanazaki H. Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia. Gynecol Oncol. 1997 Sep;66(3):393–398. doi: 10.1006/gyno.1997.4779. [DOI] [PubMed] [Google Scholar]
  44. Widrich T., Kennedy A. W., Myers T. M., Hart W. R., Wirth S. Adenocarcinoma in situ of the uterine cervix: management and outcome. Gynecol Oncol. 1996 Jun;61(3):304–308. doi: 10.1006/gyno.1996.0147. [DOI] [PubMed] [Google Scholar]
  45. Widrich T., Kennedy A. W., Myers T. M., Hart W. R., Wirth S. Adenocarcinoma in situ of the uterine cervix: management and outcome. Gynecol Oncol. 1996 Jun;61(3):304–308. doi: 10.1006/gyno.1996.0147. [DOI] [PubMed] [Google Scholar]
  46. Yamakawa Y., Forslund O., Teshima H., Hasumi K., Kitagawa T., Hansson B. G. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Gynecol Oncol. 1994 May;53(2):190–195. doi: 10.1006/gyno.1994.1114. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES